Role of β 2/3 -specific GABA-A receptor isoforms in the development of hippocampus kindling epileptogenesis
Autor: | Doodipala Samba Reddy, Derk J. Hogenkamp, Gunasekaran Ramanathan, Timothy B C Johnstone, Ryan F. Yoshimura, Chase M. Carver, Kelvin W. Gee |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Ganaxolone Allosteric modulator Chemistry Kindling GABAA receptor Pharmacology Epileptogenesis 03 medical and health sciences Behavioral Neuroscience 030104 developmental biology 0302 clinical medicine Neurology medicine Neurology (clinical) Pentylenetetrazol Kindling model Receptor 030217 neurology & neurosurgery medicine.drug |
Zdroj: | Epilepsy & Behavior. 82:57-63 |
ISSN: | 1525-5050 |
DOI: | 10.1016/j.yebeh.2018.02.020 |
Popis: | Objective Subunit-specific positive allosteric modulators (PAMs) of gamma-aminobutyric acid-A (GABA-A) receptors are commonly used to uncover the role of GABA-A receptor isoforms in brain function. Recently, we have designed novel PAMs selective for β2/3-subunit containing GABA-A receptors (β2/3-selective PAMs) that are nonbenzodiazepine site-mediated and do not show an α-subunit isoform selectivity, yet exhibit anxiolytic efficacy with reduced potential for sedation, cognitive impairment, and tolerance. In this study, we used three novel β2/3-selective PAMs (2-261, 2-262, and 10029) with differential β2/3-subunit potency to identify the role of β2/3-selective receptor isoforms in limbic epileptogenesis. Methods Experimental epileptogenesis was induced in mice by daily hippocampus stimulations until each mouse showed generalized (stage 5) seizures. Patch-clamp electrophysiology was used to record GABA-gated currents. Brain levels of β2/3-selective PAMs were determined for mechanistic correlations. Results Treatment with the β2/3-selective PAMs 2-261 (30 mg/kg), 2-262 (10 mg/kg), and 10029 (30 mg/kg), 30 min prior to stimulations, significantly suppressed the rate of development of kindled seizure activity without affecting the afterdischarge (AD) signal, indicating their disease-modifying activity. The β2/3-selective agents suppressed chemical epileptogenesis in the pentylenetetrazol model. Test doses of these agents were devoid of acute antiseizure activity in the kindling model. Conclusion These findings demonstrate that β2/3-selective PAMs can moderately retard experimental epileptogenesis, indicating the protective role of β2/3-subunit GABA-A receptor isoforms in the development of epilepsy. |
Databáze: | OpenAIRE |
Externí odkaz: |